Cytosorbents Corporation盘中异动股价大跌6.07%报0.600美元

市场透视2025-11-20

北京时间2025年11月20日22时55分，Cytosorbents Corporation（CTSO.us）股票出现异动，股价快速下跌6.07%。截至发稿，该股报0.600美元/股，成交量1489股，换手率0.00%，振幅1.80%。最近的财报数据显示，该股实现营业收入9.49百万美元，净利润-3.17百万美元，每股收益-0.05美元，毛利6.67百万美元，市盈率-3.37倍。机构评级方面，目前...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2585169426?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-20 22:55","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2585169426","market":"us","top_or_hot":-1,"title":"Cytosorbents Corporation盘中异动 股价大跌6.07%报0.600美元","media":"市场透视","content":"<div>\n<p>北京时间2025年11月20日22时55分，Cytosorbents Corporation（CTSO.us）股票出现异动，股价快速下跌6.07%。截至发稿，该股报0.600美元/股，成交量1489股，换手率0.00%，振幅1.80%。最近的财报数据显示，该股实现营业收入9.49百万美元，净利润-3.17百万美元，每股收益-0.05美元，毛利6.67百万美元，市盈率-3.37倍。机构评级方面，目前...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202255079510d02b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cytosorbents Corporation盘中异动 股价大跌6.07%报0.600美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCytosorbents Corporation盘中异动 股价大跌6.07%报0.600美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-20 22:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202255079510d02b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年11月20日22时55分，Cytosorbents Corporation（CTSO.us）股票出现异动，股价快速下跌6.07%。截至发稿，该股报0.600美元/股，成交量1489股，换手率0.00%，振幅1.80%。最近的财报数据显示，该股实现营业收入9.49百万美元，净利润-3.17百万美元，每股收益-0.05美元，毛利6.67百万美元，市盈率-3.37倍。机构评级方面，目前...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202255079510d02b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CTSO","symbol_name":"Cytosorbents Corporation","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202255079510d02b&s=b","article_id":"2585169426","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202255079510d02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2585169426","pubTimestamp":1763650507,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年11月20日22时55分，Cytosorbents Corporation股票出现异动，股价快速下跌6.07%。截至发稿，该股报0.600美元/股，成交量1489股，换手率0.00%，振幅1.80%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.12%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CTSO":"Cytosorbents Corporation","BK4082":"医疗保健设备"},"translate_title":"Cytosorbents Corporation shares fell 6.07% to $0.600 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTSO":1.5},"content_text":"北京时间2025年11月20日22时55分，Cytosorbents Corporation（CTSO.us）股票出现异动，股价快速下跌6.07%。截至发稿，该股报0.600美元/股，成交量1489股，换手率0.00%，振幅1.80%。最近的财报数据显示，该股实现营业收入9.49百万美元，净利润-3.17百万美元，每股收益-0.05美元，毛利6.67百万美元，市盈率-3.37倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.12%。其相关个股中，Nano-X Imaging Ltd、Outset Medical, Inc.、Autonomix Medical, Inc.涨幅较大，Profusa, Inc.、Autonomix Medical, Inc.、Nano-X Imaging Ltd较为活跃，换手率分别为6.17%、5.09%、3.81%，振幅较大的相关个股有Nano-X Imaging Ltd、Autonomix Medical, Inc.、Pavmed Inc.，振幅分别为14.19%、9.63%、9.08%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。收入主要来自德国的产品销售，以及来自美国赠款机构的额外收入。该公司通过美国、德国和其他国家/地区的直销和分销商/战略合作伙伴开展业务。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2585169426","isCrawlerRequest":true}

Cytosorbents Corporation盘中异动 股价大跌6.07%报0.600美元

精彩评论

Cytosorbents Corporation盘中异动股价大跌6.07%报0.600美元